Free Trial

RxSight (RXST) SEC Filings & 10K Form

RxSight logo
$29.60 -0.73 (-2.41%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$29.83 +0.23 (+0.78%)
As of 02/21/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent RxSight SEC Filings

DateFilerForm TypeView
02/14/2025
5:04 PM
BANK OF AMERICA CORP /DE/ (Filed by)
RxSight (Subject)
Form SCHEDULE 13G
02/13/2025
12:20 PM
LORD, ABBETT & CO. LLC (Filed by)
RxSight (Subject)
Form SCHEDULE 13G/A
01/27/2025
3:40 PM
Maniar Shweta (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
2:56 PM
Maniar Shweta (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:08 PM
Corley Jesse Anderson (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
5:01 AM
RxSight (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
5:38 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
12:29 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
6:25 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
6:26 PM
Maniar Shweta (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
1:45 PM
Maniar Shweta (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
8:50 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:18 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:42 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:14 PM
Corley Jesse Anderson (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
RxSight (Subject)
Form SC 13G/A
11/12/2024
3:50 PM
RxSight (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
8:40 AM
Artisan Partners Limited Partnership (Filed by)
RxSight (Subject)
Form SC 13G/A
11/08/2024
3:00 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
RxSight (Subject)
Form SC 13G/A
11/05/2024
3:05 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
3:17 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
12:52 PM
RxSight (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
4:22 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:28 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2024
7:55 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:17 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
RxSight (Subject)
Form SC 13G/A
10/22/2024
3:16 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
4:23 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:23 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
3:16 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
3:23 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:23 AM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:17 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
5:00 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:19 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:23 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
We recommended Palantir in 2021, now we’re recommending this... (Ad)

I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nice stream of income along the way.

Our research indicates ONE AI stock is poised to benefit the most.
09/30/2024
7:05 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:14 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/26/2024
3:09 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
5:48 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:41 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
4:57 PM
Kurtz Ronald M MD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:19 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
7:15 PM
RxSight (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
6:12 PM
Kurtz Ronald M MD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:54 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
2:29 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
5:45 PM
Andrews Julie (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:17 PM
LINK WILLIAM J PHD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:20 PM
Maniar Shweta (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:23 PM
PALMISANO ROBERT J (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:11 PM
RxSight (Issuer)
Tammenoms Bakker Juliet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
RxSight (Filer)
Form SD
Specialized Disclosure Report  
05/09/2024
3:59 PM
RxSight (Filer)
Form 424B5
05/08/2024
3:41 PM
RxSight (Filer)
Form 424B5
05/03/2024
10:48 AM
Kurtz Ronald M MD (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:58 PM
RxSight (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
3:33 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2024
3:30 PM
RxSight (Filer)
Form DEF 14A
04/25/2024
3:31 PM
RxSight (Filer)
Form DEFA14A
04/25/2024
3:32 PM
RxSight (Filer)
Form ARS
04/01/2024
3:18 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:24 PM
Kurtz Ronald M MD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:05 PM
RxSight (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RXST) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners